Filter
Filters Clear Filters
1031 Results

Life Science Conflict Grows from Stem Cells

The Harvard Crimson “Only a few years ago, former University President Lawrence H. Summers told alumni in Washington that Harvard could soon resemble Renaissance Florence. The...

Virus-free iPS cells

Nature, Editor’s Summary “The discovery that non-germline adult cells can be reprogrammed to become pluripotent, able to differentiate into any cell type, opened up exciting possibilities.”...

Stem cell therapy triggers tumor

The Scientist: Newsblog “A neural stem cell transplant from fetal cells performed in Russia led to a brain tumor in a teenage boy, researchers in this...

Guidelines target stem cell medical tourism

Amednews.com [American Medical News] “Growing numbers of clinics abroad are marketing unproven, costly stem cell therapies to medical tourists and “exploiting patients’ hopes,” according to a...

Pfizer to buy Wyeth in $68-billion deal

Nature News “One of the world's biggest pharmaceutical companies is set to get even larger. Pfizer announced on 26 January that it intends to acquire Wyeth,...

Stem cell transplants show promise for MS: study

Reuters “CHICAGO (Reuters) – U.S. researchers have reversed multiple sclerosis symptoms in early stage patients by using bone marrow stem cell transplants to reset the immune...

Stem Cells Ready for Prime Time

Nature News “US regulatory agency gives the go-ahead for first clinical trials of a human embryonic stem-cell treatment [by Geron].” Read more &raquo

Stem-Cell Research: The Quest Resumes

Time Magazine “Scientific inspiration can come from anywhere “Ó a person, an event, even an experiment gone awry. But perhaps nothing can drive innovation more powerfully...

U.S. Revokes Stem Cell Patent

NY Times “The United States Patent and Trademark Office has made a preliminary decision to revoke fundamental patents on human embryonic stem cells that some scientists...